CLINICAL TRIALS PROFILE FOR MICONAZOLE NITRATE
✉ Email this page to a colleague
All Clinical Trials for MICONAZOLE NITRATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00194324 ↗ | Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina | Completed | Johnson & Johnson | Phase 4 | 2004-07-01 | This study uses MRI to detect the spread of the Miconozole Nitrate OVULE within the vagina. The effect of moderate amounts of physical activity on the spread will be evaluated, and compared to no physical activity. |
| NCT00194324 ↗ | Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina | Completed | University of Pennsylvania | Phase 4 | 2004-07-01 | This study uses MRI to detect the spread of the Miconozole Nitrate OVULE within the vagina. The effect of moderate amounts of physical activity on the spread will be evaluated, and compared to no physical activity. |
| NCT00498680 ↗ | Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i | Unknown status | Rambam Health Care Campus | Phase 4 | 2007-03-01 | A prospective, randomized, 3-arm parallel trial on 45 males with ED that were never exposed to PDE5i therapy (naïve patients) will be enrolled.In each group, every patient will receive three treatment regimes (Viagra®50mg & Levitra®10mg, Viagra®100mg, Levitra®20mg), in different sequences of administration in such a manner that eventually each patient will receive all regimes in a double- blinded fasion.Safety will be evaluated at pre- screening by measuring hourly vital signs (blood pressure, heart rate)for 4 consecutive hours after taking half-dose combination. Any decrease in blood pressure of 20 mmhg below baseline will exclude the subject from the study. Effcacy will be evaluated by questionnaires (IIEF, Quality of erection questionnaire, grade of erection scale, Sear, QVS and Sexual Encounter Profiles for each sexual event). Non-parametric statistical analysis of the collected data Comparing the 3 groups will be performed. |
| NCT00702507 ↗ | Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants | Completed | GlaxoSmithKline | Phase 4 | 2007-05-01 | The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug. |
| NCT00702507 ↗ | Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants | Completed | Stiefel, a GSK Company | Phase 4 | 2007-05-01 | The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MICONAZOLE NITRATE
Condition Name
Clinical Trial Locations for MICONAZOLE NITRATE
Trials by Country
Clinical Trial Progress for MICONAZOLE NITRATE
Clinical Trial Phase
Clinical Trial Sponsors for MICONAZOLE NITRATE
Sponsor Name
